Home › Blood Cancers › NCT06296368

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Who can join

Ages 60 and older · All sexes

Inclusion Criteria In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

1. Written or verbal informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
3. Age ≥ 60 years at the time of consent.
4. New patient to either the hematologic malignancies clinic or the bone marrow transplant/cellular therapy clinic.

Exclusion Criteria

All subjects meeting any of the exclusion criteria listed below at baseline will be excluded from study participation:

1\. Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation in the intervention.

About the study

The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.

What is being tested

• Preference Reporting to Improve Management and Experience (PRIME) (behavioral)

Sponsor: UNC Lineberger Comprehensive Cancer Center · Participants: 500 · Started: Jun 21, 2024

Contact the study team

• Madisyn L Parker · Phone: 9199663036

Official record on ClinicalTrials.gov — NCT06296368

Locations in the U.S.

Conditions

• Blood Cancers
• Lymphoma
• Multiple Myeloma
• Leukemia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.